InspireMD, Inc.

NSPR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$32,005-$19,916-$18,491-$14,918
Dep. & Amort.$280$232$188$161
Deferred Tax$0$0$0$74
Stock-Based Comp.$10,138$4,490$2,352$1,576
Change in WC$736-$801$395-$75
Other Non-Cash-$1,017-$381$14-$28
Operating Cash Flow-$21,868-$16,376-$15,542-$13,210
Investing Activities
PP&E Inv.-$1,402-$381-$473-$344
Net Acquisitions$0$0$0$0
Inv. Purchases-$14,444-$40,144-$19,000-$24,000
Inv. Sales/Matur.$0$24,500$28,000$2,000
Other Inv. Act.$28,487-$67-$86-$113
Investing Cash Flow$12,641-$16,092$8,441-$22,457
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,598$37,534$0$35,034
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$16,854$0-$140$0
Financing Cash Flow$18,452$37,534-$140$35,034
Forex Effect$51-$58-$131-$8
Net Chg. in Cash$9,276$5,008-$7,372-$641
Supplemental Information
Beg. Cash$9,640$4,632$12,004$12,645
End Cash$18,916$9,640$4,632$12,004
Free Cash Flow-$23,270-$16,757-$16,015-$13,554
InspireMD, Inc. (NSPR) Financial Statements & Key Stats | AlphaPilot